Publications

Found 4 results
Filters: Author is Y.-N. Yang  [Clear All Filters]
2015
Z. - Q. Wu, Zhang, Z. - L., Nie, S. - W., Yuan, J., and Yang, Y. - N., “Activity of matrix metalloproteinases 2 and 9 in cultured rabbit corneal epithelium cells stimulated by tumor necrosis factor alpha”, vol. 14, pp. 6360-6368, 2015.
2014
X. - M. Li, Ma, Y. - T., Xie, X., Yang, Y. - N., Li, X. M., and Zheng, Y. - Y., “Relationship between serum creatinine and obesity in children in Xinjiang, China”, vol. 13, pp. 2409-2416, 2014.
2012
Y. - N. Yang, Ji, W. - N., Ma, Y. - T., Li, X. - M., Chen, B. - D., Xiang, Y., and Liu, F., “Activation of the ERK1/2 pathway by the CaMEK gene via adeno-associated virus serotype 9 in cardiomyocytes”, vol. 11, pp. 4672-4681, 2012.
Aliaga JC, Deschenes C, Beaulieu JF, Calvo EL, et al. (1999). Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells. Am. J. Physiol. 277: G631-G641. PMid:10484389   Bueno OF and Molkentin JD (2002). Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ. Res. 91: 776-781. http://dx.doi.org/10.1161/01.RES.0000038488.38975.1A PMid:12411391   Cho HS, Chang SH, Chung YS, Shin JY, et al. (2009). Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells. J. Vet. Sci. 10: 23-28. http://dx.doi.org/10.4142/jvs.2009.10.1.23 PMid:19255520 PMCid:2801106   Garrington TP and Johnson GL (1999). Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11: 211-218. http://dx.doi.org/10.1016/S0955-0674(99)80028-3   Hajjar RJ and Samulski RJ (2006). Heart failure: a silver bullet to treat heart failure. Gene Ther. 13: 997. http://dx.doi.org/10.1038/sj.gt.3302747 PMid:17262904   Hausenloy DJ, Tsang A and Yellon DM (2005). The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc. Med. 15: 69-75. http://dx.doi.org/10.1016/j.tcm.2005.03.001 PMid:15885573   Kuno Y, Kondo K, Iwata H, Senga T, et al. (1998). Tumor-specific activation of mitogen-activated protein kinase in human colorectal and gastric carcinoma tissues. Jpn. J. Cancer Res. 89: 903-909. http://dx.doi.org/10.1111/j.1349-7006.1998.tb00647.x PMid:9818025   Lemieux E, Bergeron S, Durand V, Asselin C, et al. (2009). Constitutively active MEK1 is sufficient to induce epithelial-to-mesenchymal transition in intestinal epithelial cells and to promote tumor invasion and metastasis. Int. J. Cancer 125: 1575-1586. http://dx.doi.org/10.1002/ijc.24485 PMid:19462441   Li DY, Tao L, Liu H, Christopher TA, et al. (2006). Role of ERK1/2 in the anti-apoptotic and cardioprotective effects of nitric oxide after myocardial ischemia and reperfusion. Apoptosis 11: 923-930. http://dx.doi.org/10.1007/s10495-006-6305-6 PMid:16547595   Li XM, Ma YT, Yang YN, Liu F, et al. (2009). Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure. Clin. Exp. Pharmacol. Physiol. 36: 1054-1061. http://dx.doi.org/10.1111/j.1440-1681.2009.05243.x PMid:19566828   Licato LL and Brenner DA (1998). Analysis of signaling protein kinases in human colon or colorectal carcinomas. Dig. Dis. Sci. 43: 1454-1464. http://dx.doi.org/10.1023/A:1018894227169 PMid:9690379   Lips DJ, Bueno OF, Wilkins BJ, Purcell NH, et al. (2004). MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation 109: 1938-1941. http://dx.doi.org/10.1161/01.CIR.0000127126.73759.23 PMid:15096454   Manning G, Whyte DB, Martinez R, Hunter T, et al. (2002). The protein kinase complement of the human genome. Science 298: 1912-1934. http://dx.doi.org/10.1126/science.1075762 PMid:12471243   Mebratu Y and Tesfaigzi Y (2009). How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? Cell Cycle 8: 1168-1175. http://dx.doi.org/10.4161/cc.8.8.8147 PMid:19282669 PMCid:2728430   Pacak CA, Mah CS, Thattaliyath BD, Conlon TJ, et al. (2006). Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ. Res. 99: e3-e9. http://dx.doi.org/10.1161/01.RES.0000237661.18885.f6 PMid:16873720   Prasad KM, Xu Y, Yang Z, Acton ST, et al. (2011). Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther. 18: 43-52. http://dx.doi.org/10.1038/gt.2010.105 PMid:20703310 PMCid:2988989   Simpson P and Savion S (1982). Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol. Circ. Res. 50: 101- 116. http://dx.doi.org/10.1161/01.RES.50.1.101 PMid:7053872   Treisman R (1996). Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8: 205-215. http://dx.doi.org/10.1016/S0955-0674(96)80067-6   Voisin L, Julien C, Duhamel S, Gopalbhai K, et al. (2008). Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors. BMC Cancer 8: 337. http://dx.doi.org/10.1186/1471-2407-8-337 PMid:19014680 PMCid:2596176   White JD, Thesier DM, Swain JB, Katz MG, et al. (2011). Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivo. Gene Ther. 18: 546-552. http://dx.doi.org/10.1038/gt.2010.168 PMid:21228882   Yue TL, Wang C, Gu JL, Ma XL, et al. (2000). Inhibition of extracellular signal-regulated kinase enhances Ischemia/ Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ. Res. 86: 692-699. http://dx.doi.org/10.1161/01.RES.86.6.692 PMid:10747006
2011
Y. - Y. Zheng, Xie, X., Ma, Y. - T., Yang, Y. - N., Fu, Z. - Y., Li, X. - M., Liu, F., Yang, S. - J., Ma, X., and Chen, B. - D., “S323I polymorphism of the C5L2 gene was not identified in a Chinese population with familial combined hyperlipidemia or with type 2 diabetes”, vol. 10, pp. 3256-3266, 2011.
Aouizerat BE, Allayee H, Cantor RM, Davis RC, et al. (1999). A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11. Am. J. Hum. Genet. 65: 397-412. http://dx.doi.org/10.1086/302490 PMid:10417282 Cianflone K (2003). Acylation stimulating protein and triacylglycerol synthesis: potential drug targets? Curr. Pharm. Des. 9: 1397-1410. http://dx.doi.org/10.2174/1381612033454784 PMid:12769731 Cianflone K, Xia Z and Chen LY (2003). Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim. Biophys. Acta 1609: 127-143. http://dx.doi.org/10.1016/S0005-2736(02)00686-7 Cui W, Lapointe M, Gauvreau D, Kalant D, et al. (2009a). Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation. Mol. Immunol. 46: 3207- 3217. http://dx.doi.org/10.1016/j.molimm.2009.08.013 PMid:19767107 Cui W, Simaan M, Laporte S, Lodge R, et al. (2009b). C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation. Mol. Immunol. 46: 3086-3098. http://dx.doi.org/10.1016/j.molimm.2009.06.007 PMid:19615750 de Lind van Wijngaarden RF, Cianflone K, Gao Y, Leunissen RW, et al. (2010). Cardiovascular and metabolic risk profile and acylation-stimulating protein levels in children with Prader-Willi syndrome and effects of growth hormone treatment. J. Clin. Endocrinol. Metab. 95: 1758-1766. http://dx.doi.org/10.1210/jc.2009-0656 Faraj M, Sniderman AD and Cianflone K (2004). ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes. J. Lipid Res. 45: 657-666. http://dx.doi.org/10.1194/jlr.M300299-JLR200 PMid:14703506 Huertas-Vazquez A, Aguilar-Salinas C, Lusis AJ, Cantor RM, et al. (2005). Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1. Arterioscler. Thromb. Vasc. Biol. 25: 1985-1991. http://dx.doi.org/10.1161/01.ATV.0000175297.37214.a0 PMid:15976322 Kalant D, MacLaren R, Cui W, Samanta R, et al. (2005). C5L2 is a functional receptor for acylation-stimulating protein. J. Biol. Chem. 280: 23936-23944. http://dx.doi.org/10.1074/jbc.M406921200 PMid:15833747 MacLaren R, Kalant D and Cianflone K (2007). The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance. Biochem. Cell Biol. 85: 11-21. http://dx.doi.org/10.1139/o06-207 PMid:17464341 Marcil M, Vu H, Cui W, Dastani Z, et al. (2006). Identification of a novel C5L2 variant (S323I) in a French Canadian family with familial combined hyperlipemia. Arterioscler. Thromb. Vasc. Biol. 26: 1619-1625. http://dx.doi.org/10.1161/01.ATV.0000222907.72985.0b PMid:16627811 Maslowska M, Wang HW and Cianflone K (2005). Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence. Vitam. Horm. 70: 309-332. http://dx.doi.org/10.1016/S0083-6729(05)70010-8 Paglialunga S, Julien P, Tahiri Y, Cadelis F, et al. (2009). Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels. J. Lipid Res. 50: 1109-1119. http://dx.doi.org/10.1194/jlr.M800430-JLR200 PMid:19237736    PMCid:2681393 Saleh J, Al-Khanbashi M, Al-Maarof M, Al-Lawati M, et al. (2009). Acylation-stimulating protein increases and correlates with increased progesterone levels during the luteal phase of the menstrual cycle. Eur. J. Endocrinol. 160: 301-307. http://dx.doi.org/10.1530/EJE-08-0784 PMid:19022911 Xiang SQ, Cianflone K, Kalant D and Sniderman AD (1999). Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase. J. Lipid Res. 40: 1655-1663. PMid:10484612 Xiang X, Ma YT, Fu ZY, Yang YN, et al. (2009). Haplotype analysis of the CYP8A1 gene associated with myocardial infarction. Clin. Appl. Thromb. Hemost. 15: 574-580. http://dx.doi.org/10.1177/1076029608329581 PMid:19147528 Xie X, Ma YT, Fu ZY, Yang YN, et al. (2009). Association of polymorphisms of PTGS2 and CYP8A1 with myocardial infarction. Clin. Chem. Lab. Med. 47: 347-352. http://dx.doi.org/10.1515/CCLM.2009.078 PMid:19327107 Xie X, Ma YT, Yang YN, Li XM, et al. (2010a). Alcohol consumption and ankle-to-brachial index: results from the Cardiovascular Risk Survey. PLoS One 5: e15181. http://dx.doi.org/10.1371/journal.pone.0015181 PMid:21152041    PMCid:2996294 Xie X, Ma YT, Yang YN, Fu ZY, et al. (2010b). Polymorphisms in the SAA1/2 gene are associated with carotid intima media thickness in healthy Han Chinese subjects: the Cardiovascular Risk Survey. PLoS One 5: e13997. http://dx.doi.org/10.1371/journal.pone.0013997 PMid:21103356    PMCid:2982816 Yang YN, Wang XL, Ma YT, Xie X, et al. (2010). Association of interaction between smoking and CYP 2C19*3 polymorphism with coronary artery disease in a Uighur population. Clin. Appl. Thromb. Hemost. 16: 579-583. http://dx.doi.org/10.1177/1076029610364522 PMid:20460345